Drug Trial Radar · NCT00402428
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
Last checked: Nov 19, 2026Latest source record: Aug 8, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,331
Actual
Start
Dec 2006
Primary completion
Feb 2009
Study completion Feb 2009
Sponsor
- Lead sponsor
- Human Genome Sciences Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Novartis
- First posted
- Nov 22, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 3, randomized, multi-center study to evaluate the efficacy and safety of albumin interferon alfa 2b (alb-IFN)in combination with ribavirin compared with peginterferon alfa-2a (PEGASYS or PEG-IFNa2a) in combination with ribavirin in subjects with chronic hepatitis C, genotype 1 who are IFNa treatment naive.
Conditions
- Chronic Hepatitis C
Interventions
albumin interferon alfa-2bDrug
900 mcg or 1200mcg every two week for 48 weeks
peginterferon alfa-2aDrug
180 mcg once a week for 48 weeks
RibavirinDrug
1000 mg/day(for subjects \<75kg) or 1200 mg/day (for subjects =,\> 75kg)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sustained virologic response (SVR)Time frame: Week 72
Locations
165 sites in 15 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Mayo Clinic Hospital
Phoenix, Arizona
UCSF Fresno
Fresno, California
Scripps Clinic
La Jolla, California
USC Keck School of Medicine
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
UCLA / West LA VAMC
Los Angeles, California
Huntington Medical Research Institutes
Pasadena, California
University California-San Diego
San Diego, California
San Diego Digestive Diseases Consultants, Inc
San Diego, California
VA San Diego Healthcare
San Diego, California
California Pacific Medical Center
San Francisco, California
University of California at San Francisco
San Francisco, California
University of Colorado
Denver, Colorado
University of Colorado Health Sciences Ctr
Englewood, Colorado
Walter Reed Army Medical Center
Washington D.C., District of Columbia
University of Florida - Gainesville
Gainesville, Florida
Shands Jacksonville Medical Center
Jacksonville, Florida
Mayo Clinic Transplant Center
Jacksonville, Florida
Va Health Care System
Miami, Florida
University of Miami
Miami, Florida
Venture Research Institute
North Miami Beach, Florida
University Hepatitis Center
Sarasota, Florida
Atlanta Gastroenterology Associates
Atlanta, Georgia
GI of Atlanta
Atlanta, Georgia
Northwest Georgia Gastroenterology Associates
Marietta, Georgia
Alan D Tice, MD, LLC
Honolulu, Hawaii
Northwestern Memorial Hospital
Chicago, Illinois
Indiania University School of Medicine
Indianapolis, Indiana
University of Iowa Hospitals and Clinics
Iowa City, Iowa
University of Louisville
Louisville, Kentucky
Tulane University Health Sciences Center
New Orleans, Louisiana
University of Maryland
Baltimore, Maryland
Johns Hopkins Center for Viral Hepatits
Baltimore, Maryland
Maryland Digestive Disease Center
Laurel, Maryland
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Henry Ford Health System
Detroit, Michigan
Mayo Clinic
Rochester, Minnesota
Digestive Health Specialist
Tupelo, Mississippi
St. Louis University
St Louis, Missouri
Showing 40 of 165 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.